Arcutis Biotherapeutics, Inc. (ARQT)

NASDAQ: ARQT · Real-Time Price · USD

26.19

+0.36 (1.39%)

At close: Aug 14, 2026, 4:00 PM EDT

25.88

-0.31 (-1.18%)

After-hours: Aug 14, 2026, 7:51 PM EDT

Arcutis Biotherapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	28.52	-16.14	-140.04	-262.14	-311.46	-206.36
Depreciation & Amortization	2.25	4.67	1.96	0.75	0.93	0.45
Asset Writedown & Restructuring Costs	-	-	-	-	29.63	-
Loss (Gain) From Sale of Investments	-0.95	-2.09	-6.9	-6.99	-2.25	3.45
Stock-Based Compensation	43.55	40.36	41.73	38.81	32.68	23.89
Other Operating Activities	2.65	2.41	6.17	6.01	2.93	0.31
Change in Accounts Receivable	-48.48	-73.16	-47.26	-17.35	-8.46	-
Change in Inventory	-21.65	-7.33	-0.4	-5.62	-7.51	-
Change in Accounts Payable	-8.48	-1.69	2.23	3.15	1.57	0.25
Change in Other Net Operating Assets	41.9	47.36	30.35	-3.68	4.23	3.38
Operating Cash Flow	39.31	-5.63	-112.16	-247.06	-257.72	-174.63
Operating Cash Flow Growth	-	-	-	-	-	-
Capital Expenditures	-0.16	-0.69	-0.14	-0.43	-0.33	-1
Sale (Purchase) of Intangibles	-	-10	-5	-	-22.95	-
Investment in Securities	-85.82	-19.57	33.96	180.66	-63.92	-74.96
Investing Cash Flow	-85.98	-30.25	28.82	180.23	-87.2	-75.95
Long-Term Debt Issued	-	-	-	-	125	73.99
Long-Term Debt Repaid	-	-	-100	-	-	-
Net Debt Issued (Repaid)	-	-	-100	-	125	73.99
Issuance of Common Stock	9.26	6.97	166.2	101.32	178.99	209.6
Other Financing Activities	-1	-	-	-	-2.19	-1.64
Financing Cash Flow	8.26	6.97	66.2	101.32	301.8	281.95
Foreign Exchange Rate Adjustments	-0.2	0.17	-0.24	-0.05	-	-
Net Cash Flow	-38.62	-28.74	-17.37	34.45	-43.12	31.37
Free Cash Flow	39.15	-6.31	-112.3	-247.49	-258.05	-175.62
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Margin	8.44%	-1.68%	-57.14%	-415.20%	-7000.76%	-
Free Cash Flow Per Share	0.30	-0.05	-0.93	-3.57	-4.69	-3.56
Levered Free Cash Flow	21.69	-15.7	-72.9	-152.09	-195.81	-102.77
Unlevered Free Cash Flow	30.34	-8.15	-55.92	-133.52	-186.03	-102.77
Cash Interest Paid	11.99	10.33	22.21	25.45	12.64	0.14
Change in Working Capital	-36.71	-34.83	-15.08	-23.5	-10.18	3.62

SEC Filings: 10-K · 10-Q